Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
19.19
-0.37 (-1.89%)
Apr 1, 2026, 2:56 PM EDT - Market open
Viridian Therapeutics Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$38.25
Upside
+99.32%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $41 → $36 | Strong Buy | Maintains | $41 → $36 | +87.60% | Mar 31, 2026 |
| Wedbush | Wedbush | Buy Maintains $44 → $37 | Buy | Maintains | $44 → $37 | +92.81% | Mar 31, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $29 → $20 | Hold | Maintains | $29 → $20 | +4.22% | Mar 31, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $34 → $22 | Strong Buy | Maintains | $34 → $22 | +14.64% | Mar 31, 2026 |
| Needham | Needham | Strong Buy Maintains $42 → $32 | Strong Buy | Maintains | $42 → $32 | +66.75% | Mar 30, 2026 |
| Wedbush | Wedbush | Buy Reiterates $44 | Buy | Reiterates | $44 | +129.29% | Mar 11, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $45 → $42 | Buy | Maintains | $45 → $42 | +118.86% | Feb 27, 2026 |
| Needham | Needham | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +118.86% | Feb 4, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $26 → $29 | Hold | Maintains | $26 → $29 | +51.12% | Feb 3, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $41 → $40 | Strong Buy | Maintains | $41 → $40 | +108.44% | Jan 8, 2026 |
| UBS | UBS | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +160.55% | Jan 7, 2026 |
| Needham | Needham | Strong Buy Maintains $34 → $42 | Strong Buy | Maintains | $34 → $42 | +118.86% | Dec 23, 2025 |
| Wedbush | Wedbush | Buy Maintains $42 → $47 | Buy | Maintains | $42 → $47 | +144.92% | Dec 10, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 3, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $41 | Strong Buy | Initiates | $41 | +113.65% | Nov 24, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $41 → $45 | Buy | Maintains | $41 → $45 | +134.50% | Nov 6, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.